출혈성 뇌졸중 치료 기기 시장 : 기기 종류별, 뇌졸중 종류별, 시술 종류별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Hemorrhagic Stroke Treatment Devices Market size was valued at US$ 1,084.23 Million in 2024, expanding at a CAGR of 7.12% from 2025 to 2032.

The hemorrhagic stroke treatment devices market focuses on medical devices used to manage bleeding-type strokes, mainly intracerebral hemorrhage and subarachnoid hemorrhage, including cases linked to ruptured brain aneurysms. These events are treated as medical emergencies, and the choice of devices can affect how quickly bleeding is controlled, whether re-bleeding is prevented, and how patients recover over time. The market includes endovascular tools such as coils, flow diverters, and stent-assisted systems used to seal aneurysms from inside the blood vessel, along with surgical tools like aneurysm clips used in open procedures when required.

Demand is connected to factors such as aging populations, high blood pressure and vascular risk, and the expansion of hospitals with neurointerventional capabilities. Buying decisions in this market are usually based on clinical outcomes, safety and complication rates, how easy devices are to use in complex anatomy, compatibility with existing hospital systems, and the overall cost per treated case, which makes product performance and evidence an important part of vendor competition.

Hemorrhagic Stroke Treatment Devices Market- Market Dynamics

High Stroke Burden and Better Access to Stroke Centers Are Increasing Use of Hemorrhagic Treatment Devices

A major driver for the hemorrhagic stroke treatment devices market is the ongoing stroke burden and the steady expansion of organized stroke care, which increases the number of patients reaching hospitals that can perform aneurysm repair and other neurovascular procedures. Stroke remains a major public health issue in the U.S.: According to the U.S. Centers for Disease Control and Prevention (CDC, stroke updates published during 2023-2024), stroke affects hundreds of thousands of people each year and continues to rank among the leading causes of long-term disability, which keeps hospitals focused on improving acute stroke pathways and clinical outcomes. Globally, the overall mortality impact stays high: According to World Health Organization (WHO) updates released during 2022-2024, stroke remains among the top causes of death worldwide, with hypertension and aging populations continuing to support risk levels. System changes also matter because routing and treatment networks influence procedure volume at capable sites: According to U.S. government and state public health/EMS stroke-system materials compiled across 2020-2024 (including HRSA-supported and state stroke program reporting), more regions have strengthened stroke triage and destination protocols, which increases the concentration of severe stroke cases at higher-level centers where endovascular and surgical device use is more common. For hospital buyers and neurointerventional teams, this directly supports demand for coils, flow diverters, stents, and clipping systems that can reduce re-bleeding risk, improve procedural safety, and help shorten ICU and hospital stays.

Hemorrhagic Stroke Treatment Devices Market- Segmentation Analysis:

More hemorrhagic stroke care is moving toward catheter-based treatment pathways, especially for aneurysm-related bleeding, because these procedures can be performed faster in specialized centers and can reduce the burden of open surgery in many cases. The overall volume base remains large: According to the U.S. Centers for Disease Control and Prevention (CDC, stroke information updated during 2023-2024), stroke affects hundreds of thousands of people each year in the United States, keeping emergency stroke workflows active and supporting steady use of neurovascular devices in hospitals that can treat complex cases. Access factors also keep improving because stroke systems continue to formalize routing and care networks: According to state health department stroke-system plans and EMS destination protocol updates published during 2020-2024, more regions have implemented structured triage rules that direct severe stroke patients to higher-capability stroke centers, which increases the number of hemorrhagic cases evaluated for endovascular repair using coils, stents, and flow-diversion technologies. In purchasing terms, this pushes demand toward devices that can navigate difficult anatomy, simplify procedure steps, and reduce complications that extend ICU stays.

Clinical needs also differ based on whether bleeding occurs inside the brain tissue or around the brain, and this affects which tools are required and how quickly definitive treatment must happen. The broader disease burden remains serious globally: According to World Health Organization (WHO, updates released during 2022-2024), stroke continues to rank among the top causes of death worldwide, and long-term drivers such as hypertension and aging populations keep the risk environment high. Hospital workflow pressure supports faster diagnosis and treatment readiness: According to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient and quality program updates released during 2020-2024, hospitals operate under ongoing quality and reporting expectations that reinforce standardized acute-care processes, which support investment in stroke-team capability and procedure-ready device availability. For hospital committees and neurointerventional teams, this generally translates into demand for device platforms that improve speed and consistency during aneurysm securing and reduce the risk of re-bleeding and procedure-related complications.

Hemorrhagic Stroke Treatment Devices Market- Geographical Insights

Geographically, demand for hemorrhagic stroke treatment devices tends to be higher in healthcare systems that have organized stroke networks and enough specialized hospitals to run neurointerventional services around the clock. North America and parts of Europe generally benefit from established triage systems and strong hospital spending on advanced procedures, while Asia-Pacific has a large patient base and is expanding higher-level hospital capabilities in major cities. The size of the clinical need remains a major baseline driver: According to the U.S. Centers for Disease Control and Prevention (CDC, updates published during 2023-2024), stroke affects hundreds of thousands of people each year in the United States, which supports consistent demand for aneurysm-repair tools and other neurovascular devices in stroke-capable hospitals. The global burden also stays significant: According to World Health Organization (WHO, updates released during 2022-2024), stroke remains among the top causes of death worldwide, keeping long-term pressure on emergency care capacity and the devices used to treat high-acuity bleeding events.

United States Hemorrhagic Stroke Treatment Devices Market- Country Insights

The United States stands out as a strong country market because of scale, strong reimbursement capacity, and a large base of hospitals that maintain stroke readiness and can adopt newer endovascular technologies. High stroke burden continues to support procedure activity: According to CDC (2023-2024 stroke updates), stroke remains a leading cause of serious disability and still impacts hundreds of thousands of people per year, which keeps hospital investment focused on faster diagnosis and intervention capability. Hospital incentives and workflow standards also influence procurement: According to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient payment and quality-program updates released during 2020-2024, hospitals operate under ongoing reporting and performance expectations that reinforce standardized acute stroke pathways, supporting purchasing of endovascular device inventories and surgical tools needed for hemorrhagic stroke care.

Hemorrhagic Stroke Treatment Devices Market- Competitive Landscape:

The competitive landscape is led by companies with deep neurovascular portfolios and strong clinical support, since success depends on evidence, physician training, and consistent device performance in complex anatomy. Medtronic plc and Stryker Corporation are often referenced for broad neurovascular product lines and strong positioning in major stroke centers, which helps with hospital standardization and contracting. Terumo Corporation and MicroVention, Inc. are typically linked with catheter and coil systems designed for controlled deployment and access in challenging vessels. Penumbra, Inc. is commonly associated with aspiration and procedure-support systems used in neurointervention settings where speed matters. Boston Scientific Corporation, Abbott Laboratories, and Johnson & Johnson Services, Inc. are usually seen as large-scale competitors with distribution strength and clinical infrastructure, supporting adoption across wider hospital networks. Across these vendors, competitive strength generally comes down to device deliverability, complication management, training programs, and post-market clinical data, which are the main factors used by hospital committees when selecting hemorrhagic stroke treatment platforms.

Recent Developments:

In November 2024, AIIMS Delhi and a consortium of 16 Indian hospitals (public and private hospitals providing advanced stroke care) partnered to launch the GRASSROOT clinical trial to evaluate Gravity Medical Technology's (stroke treatment device developer) stent-retriever designed for mechanical thrombectomy in Indian patients with large vessel occlusion stroke; the program was positioned around India's high stroke burden of about 1.7 million strokes annually, an estimated 375,000 patients who could benefit each year from interventional stroke treatment, and the gap that only about 4,500-5,000 patients received thrombectomy in 2023 due to access and cost, with a stated goal to bring device pricing down to roughly one-quarter of current levels.

In May 2024, IIIT Bangalore (research and engineering institute) unveiled XoRehab (an IoT-enabled rehabilitation wheelchair device) developed through the Centre for the Internet of Ethical Things with support from government and international partners, designed to help stroke patients continue physiotherapy after hospital discharge using surface EMG tracking and a 9-degree-of-freedom assistive suit for upper and lower limb movement; the device was positioned for hospital purchase at around ₹85,000-₹90,000 with a rental model to improve access for patients who struggle to attend frequent in-person therapy sessions.

In September 2021, Hyperfine, Inc. (medical imaging technology company) announced results from a Yale New Haven Hospital study of its FDA-cleared portable MRI system Swoop, showing performance for hemorrhagic stroke detection including 96.6% specificity (85/88) for blood-negative cases and 80.4% sensitivity (45/56) for intracerebral hemorrhage detection across 144 exams, with later-study software versions reaching 90.5% overall accuracy and 85.3% sensitivity (29/34); the company highlighted the bedside design as a way to reduce ICU patient transport risks and support faster stroke assessment where conventional CT/MRI access is limited.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Abbott Laboratories
• B. Braun SE
• Balt USA, LLC
• Boston Scientific Corporation
• Cook Medical LLC
• Integer Holdings Corporation
• Johnson & Johnson Services, Inc.
• Kaneka Corporation
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroVention, Inc.
• Natus Medical Incorporated
• Nihon Kohden Corporation
• Penumbra, Inc.
• Phenox GmbH
• Rapid Medical Ltd.
• Stryker Corporation
• Terumo Corporation
• W. L. Gore & Associates, Inc.
• Wallaby Medical Holding, Inc.
• Others

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

• Aneurysm Coiling Devices
• Flow Diverters
• Aneurysm Clips
• Stent-Assisted Coiling Systems
• Aspiration & Thrombectomy Systems

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032

• Intracerebral Hemorrhage (ICH)
• Subarachnoid Hemorrhage (SAH)

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032

• Endovascular Procedures
• Surgical Procedures

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Hemorrhagic Stroke Treatment Devices Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Hemorrhagic Stroke Treatment Devices Market Snippet by Device Type
  • 2.1.2. Hemorrhagic Stroke Treatment Devices Market Snippet by Stroke Type
  • 2.1.3. Hemorrhagic Stroke Treatment Devices Market Snippet by Procedure Type
  • 2.1.4. Hemorrhagic Stroke Treatment Devices Market Snippet by End User
  • 2.1.5. Hemorrhagic Stroke Treatment Devices Market Snippet by Country
  • 2.1.6. Hemorrhagic Stroke Treatment Devices Market Snippet by Region
• 2.2. Competitive Insights

3. Hemorrhagic Stroke Treatment Devices Key Market Trends

• 3.1. Hemorrhagic Stroke Treatment Devices Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Hemorrhagic Stroke Treatment Devices Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Hemorrhagic Stroke Treatment Devices Market Opportunities
• 3.4. Hemorrhagic Stroke Treatment Devices Market Future Trends

4. Hemorrhagic Stroke Treatment Devices Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Hemorrhagic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Hemorrhagic Stroke Treatment Devices Market Landscape

• 6.1. Hemorrhagic Stroke Treatment Devices Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Hemorrhagic Stroke Treatment Devices Market - By Device Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
  • 7.1.2. Aneurysm Coiling Devices
  • 7.1.3. Flow Diverters
  • 7.1.4. Aneurysm Clips
  • 7.1.5. Stent-Assisted Coiling Systems
  • 7.1.6. Aspiration & Thrombectomy Systems

8. Hemorrhagic Stroke Treatment Devices Market - By Stroke Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
  • 8.1.2. Intracerebral Hemorrhage (ICH)
  • 8.1.3. Subarachnoid Hemorrhage (SAH)

9. Hemorrhagic Stroke Treatment Devices Market - By Procedure Type

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
  • 9.1.2. Endovascular Procedures
  • 9.1.3. Surgical Procedures

10. Hemorrhagic Stroke Treatment Devices Market - By End User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
  • 10.1.2. Hospitals
  • 10.1.3. Specialty Clinics
  • 10.1.4. Ambulatory Surgical Centers

11. Hemorrhagic Stroke Treatment Devices Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hemorrhagic Stroke Treatment Devices Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Abbott Laboratories
  • 12.2.2. B. Braun SE
  • 12.2.3. Balt USA, LLC
  • 12.2.4. Boston Scientific Corporation
  • 12.2.5. Cook Medical LLC
  • 12.2.6. Integer Holdings Corporation
  • 12.2.7. Johnson & Johnson Services, Inc.
  • 12.2.8. Kaneka Corporation
  • 12.2.9. Medtronic plc
  • 12.2.10. Merit Medical Systems, Inc.
  • 12.2.11. MicroVention, Inc.
  • 12.2.12. Natus Medical Incorporated
  • 12.2.13. Nihon Kohden Corporation
  • 12.2.14. Penumbra, Inc.
  • 12.2.15. Phenox GmbH
  • 12.2.16. Rapid Medical Ltd.
  • 12.2.17. Stryker Corporation
  • 12.2.18. Terumo Corporation
  • 12.2.19. W. L. Gore & Associates, Inc.
  • 12.2.20. Wallaby Medical Holding, Inc.
  • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us